Authors

• Laura Farnan (ORCID: https://orcid.org/0000-0001-9240-4974)
• Erin E. Kent (ORCID: https://orcid.org/0000-0003-2503-2191)
• H. Shelton Earp (ORCID: https://orcid.org/0000-0003-1229-4619)
• Andrew F. Olshan (ORCID: https://orcid.org/0000-0001-9115-5128)
• Chelsea Anderson (ORCID: https://orcid.org/0000-0001-6535-481X)
• Jeannette T. Bensen (ORCID: https://orcid.org/0000-0003-4972-0087)
• Hazel B. Nichols (ORCID: https://orcid.org/0000-0003-0972-1560)
• Emma H. Allott (ORCID: https://orcid.org/0000-0003-1227-3615)
• Patricia V. Basta
• Debra E. Irwin
• Hung‐Jui Tan (ORCID: https://orcid.org/0000-0002-9681-4919)
• Tzy‐Mey Kuo (ORCID: https://orcid.org/0000-0003-0700-5990)
• Adrian Gerstel
• Christopher D. Baggett

Institutions

• University of North Carolina at Chapel Hill (US)
• Queen's University Belfast (GB)
• The Northern Ireland Cancer Centre (GB)
• Department of Health (ZA)
• UNC Lineberger Comprehensive Cancer Center

Publication Details

Journal

Cancer Epidemiology Biomarkers & Prevention

Published

2024-09-06

DOI

https://doi.org/10.1158/1055-9965.epi-24-0794

Citations

4

Primary Topic

Cancer-related cognitive impairment studies

Type

article

Field-Weighted Citation Impact

1.68